| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2134487 | Experimental Hematology | 2010 | 11 Pages |
Abstract
The DPP2 apoptosis assay provides a reliable prognostic factor in CLL. CLL B cells sensitive to DPP2 inhibition are in true G0, while resistant CLL B-cells are partially activated. DPP2 inhibition alone or with concomitant inhibition of heat shock protein 90 warrants investigation as a therapeutic modality in CLL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexey V. Danilov, Olga V. Danilova, Jennifer R. Brown, Arthur Rabinowitz, Andreas K. Klein, Brigitte T. Huber,